Rchr

J-GLOBAL ID：200901012044344935 Update date: Aug. 29, 2020

Kawai Yasukazu

カワイヤスカズ | Kawai Yasukazu

Affiliation and department：
Job title： Research Associate

Research field (1)： Pharmacology

Research keywords (2)：分子薬理学 , Molecular Pharmacology

Research theme for competitive and other funds (1)：

1999 - 白血病細胞のストレス応答シグナルと薬剤感受性の関連

MISC (101)：

N Yoshio, Y Kawai, H Hori, T Ueda. Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: Implications for different sensitivities to nucleoside analogues. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2005. 81. 5. 405-412
M Towatari, M Yanada, N Usui, J Takauchi, Sugiura, I, M Takeuchi, F Yagasaki, Y Kawai, S Miyawaki, S Ohtake, et al. Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. BLOOD. 2004. 104. 12. 3507-3512
K Takagi, Y Kawai, T Yamauchi, T Ueda. Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes. BIOCHEMICAL PHARMACOLOGY. 2004. 68. 9. 1757-1766
Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes. Biochem Phamacol. 2004. 68. 9. 1757-66
Reduced intensity allogeneic stem cell transplantation for systemic primary amyloidosis refractory to high-dose melphalan. Eur J Haematol. 2004. 72. 6. 448-50

ｍore...

Education (2)：

- 1994 Fukui Medical University
- 1988 Fukui Medical University

Professional career (1)：

医学 (福井医科大学)

Work history (2)：

1999 - 2002 Fukui Medical University
1997 - 1999 米国 MD Anderson 癌研究所 Post doctnal fellow

Association Membership(s) (2)：

日本血液学会 , 日本癌学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM